These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 31247150)

  • 1. ARHGAP21 deficiency impairs hepatic lipid metabolism and improves insulin signaling in lean and obese mice.
    Zangerolamo L; Soares GM; Vettorazzi JF; do Amaral ME; Carneiro EM; Olalla-Saad ST; Boschero AC; Barbosa-Sampaio HC
    Can J Physiol Pharmacol; 2019 Nov; 97(11):1018-1027. PubMed ID: 31247150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole body ARHGAP21 reduction improves glucose homeostasis in high-fat diet obese mice.
    Soares GM; Zangerolamo L; Azevedo EG; Costa-Júnior JM; Carneiro EM; Saad ST; Boschero AC; Barbosa-Sampaio HC
    J Cell Physiol; 2018 Sep; 233(9):7112-7119. PubMed ID: 29574752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice.
    Taher J; Baker C; Alvares D; Ijaz L; Hussain M; Adeli K
    Endocrinology; 2018 Sep; 159(9):3340-3350. PubMed ID: 30052880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity.
    Wang XX; Ye T; Li M; Li X; Qiang O; Tang CW; Liu R
    Mol Med Rep; 2017 Jul; 16(1):109-118. PubMed ID: 28534956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in mice.
    Sheng L; Liu Y; Jiang L; Chen Z; Zhou Y; Cho KW; Rui L
    PLoS One; 2013; 8(12):e83269. PubMed ID: 24358267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term strength training reduces gluconeogenesis and NAFLD in obese mice.
    Pereira RM; Rodrigues KCDC; Anaruma CP; Sant'Ana MR; de Campos TDP; Gaspar RS; Canciglieri RDS; de Melo DG; Mekary RA; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
    J Endocrinol; 2019 Apr; 241(1):59-70. PubMed ID: 30878016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial deficiency of CTRP12 alters hepatic lipid metabolism.
    Tan SY; Little HC; Lei X; Li S; Rodriguez S; Wong GW
    Physiol Genomics; 2016 Dec; 48(12):936-949. PubMed ID: 27815536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
    Khound R; Taher J; Baker C; Adeli K; Su Q
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-Body ARHGAP21-Deficiency Improves Energetic Homeostasis in Lean and Obese Mice.
    Soares GM; Zangerolamo L; Costa-Júnior JM; Vettorazzi JF; Carneiro EM; Saad ST; Boschero AC; Barbosa-Sampaio HC
    Front Endocrinol (Lausanne); 2019; 10():338. PubMed ID: 31191459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ergogenic supplement β-hydroxy-β-methylbutyrate (HMB) attenuates insulin resistance through suppressing GLUT-2 in rat liver.
    Sharawy MH; El-Awady MS; Megahed N; Gameil NM
    Can J Physiol Pharmacol; 2016 May; 94(5):488-97. PubMed ID: 26871756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered hepatic glucose homeostasis in AnxA6-KO mice fed a high-fat diet.
    Cairns R; Fischer AW; Blanco-Munoz P; Alvarez-Guaita A; Meneses-Salas E; Egert A; Buechler C; Hoy AJ; Heeren J; Enrich C; Rentero C; Grewal T
    PLoS One; 2018; 13(8):e0201310. PubMed ID: 30110341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferulic acid improves lipid and glucose homeostasis in high-fat diet-induced obese mice.
    Naowaboot J; Piyabhan P; Munkong N; Parklak W; Pannangpetch P
    Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):242-50. PubMed ID: 26541794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver-specific knockdown of long-chain acyl-CoA synthetase 4 reveals its key role in VLDL-TG metabolism and phospholipid synthesis in mice fed a high-fat diet.
    Singh AB; Kan CFK; Kraemer FB; Sobel RA; Liu J
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E880-E894. PubMed ID: 30721098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
    Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
    Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morin attenuates hepatic insulin resistance in high-fat-diet-induced obese mice.
    Naowaboot J; Wannasiri S; Pannangpetch P
    J Physiol Biochem; 2016 Jun; 72(2):269-80. PubMed ID: 26976296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbenoxolone ameliorates hepatic lipid metabolism and inflammation in obese mice induced by high fat diet via regulating the JAK2/STAT3 signaling pathway.
    Chen Y; Lu W; Jin Z; Yu J; Shi B
    Int Immunopharmacol; 2019 Sep; 74():105498. PubMed ID: 31261036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
    Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.